Laparoscopic colorectal resection combined with simultaneous thermal ablation or surgical resection of liver metastasis: a retrospective comparative study

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer Oxf Engl 1990. 2013;49:1374–1403.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Inoue Y, Komeda K, et al. Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis. BMC Surg. 2010;10:27.
   PubMed Web of Science ®Google Scholar
• Kanas GP, Taylor A, Primrose JN, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283–301.
   PubMedGoogle Scholar
• Adams RB, Aloia TA, Loyer E, et al.; Americas Hepato-Pancreato-Biliary Association, Society of Surgical Oncology, Society for Surgery of the Alimentary Tract. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford). 2013;15:91–103.
   PubMed Web of Science ®Google Scholar
• Weber JC, Bachellier P, Oussoultzoglou E, et al. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg. 2003;90:956–962.
   PubMed Web of Science ®Google Scholar
• Vallance AE, van der Meulen J, Kuryba A, et al. The timing of liver resection in patients with colorectal cancer and synchronous liver metastases: a population-based study of current practice and survival. Colorectal Dis. 2018;20:486–495.
   PubMed Web of Science ®Google Scholar
• Karanicolas PJ, Jarnagin WR, Gonen M, et al. Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. JAMA Surg. 2013;148:597–601.
   PubMed Web of Science ®Google Scholar
• Hof J, Wertenbroek M, Peeters P, et al. Outcomes after resection and/or radiofrequency ablation for recurrence after treatment of colorectal liver metastases. Br J Surg. 2016;103:1055–1062.
   PubMed Web of Science ®Google Scholar
• Eltawil KM, Boame N, Mimeault R, et al. Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases. J Surg Oncol. 2014;110:734–738.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol off J Eur Soc Med Oncol. 2016;27:1386–1422.
   PubMed Web of Science ®Google Scholar
• Mayo SC, Pulitano C, Marques H, et al. Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis. J Am Coll Surg. 2013; 216:707–716.
   PubMed Web of Science ®Google Scholar
• Mentha G, Roth AD, Terraz S, et al. ‘Liver first’ approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg. 2008;25:430–435.
   PubMed Web of Science ®Google Scholar
• Jegatheeswaran S, Mason JM, Hancock HC, et al. The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review. JAMA Surg. 2013;148:385–391.
   PubMed Web of Science ®Google Scholar
• Peeters C, de Waal RMW, Wobbes T, et al. Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation. Int J Cancer. 2006; 119:1249–1253.
   PubMed Web of Science ®Google Scholar
• Scheer MGW, Stollman TH, Vogel WV, et al. Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor. J Nucl Med. 2008;49:887–891.
   PubMed Web of Science ®Google Scholar
• van der Wal GE, Gouw ASH, Kamps J, et al. Angiogenesis in synchronous and metachronous colorectal liver metastases: the liver as a permissive soil. Ann Surg. 2012; 255:86–94.
   PubMed Web of Science ®Google Scholar
• Slesser AA, Khan F, Chau I, et al. The effect of a primary tumour resection on the progression of synchronous colorectal liver metastases: an exploratory study. Eur J Surg Oncol. 2015;41:484–492.
   PubMed Web of Science ®Google Scholar
• Reddy SK, Pawlik TM, Zorzi D, et al. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol. 2007;14:3481–3491.
   PubMed Web of Science ®Google Scholar
• Muangkaew P, Cho JY, Han H-S, et al. Outcomes of simultaneous major liver resection and colorectal surgery for colorectal liver metastases. J Gastrointest Surg. 2016;20:554–563.
   PubMed Web of Science ®Google Scholar
• Nanji S, Mackillop WJ, Wei X, et al. Simultaneous resection of primary colorectal cancer and synchronous liver metastases: a population-based study. Can J Surg. 2017;60:122–128.
   PubMed Web of Science ®Google Scholar
• Tzeng CWD, Cooper AB, Vauthey JN, et al. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford). 2014; 16:459–468.
   PubMed Web of Science ®Google Scholar
• Sato M, Tateishi R, Yasunaga H, et al. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol. 2012;47:1125–1133.
   PubMed Web of Science ®Google Scholar
• Oshowo A, Gillams AR, Lees WR, et al. Radiofrequency ablation extends the scope of surgery in colorectal liver metastases. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2003;29:244–247.
   Google Scholar
• Evrard S, Becouarn Y, Fonck M, et al. Surgical treatment of liver metastases by radiofrequency ablation, resection, or in combination. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2004;30:399–406.
   Google Scholar
• Hammill CW, Billingsley KG, Cassera MA, et al. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases. Ann Surg Oncol. 2011;18:1947–1954.
   PubMed Web of Science ®Google Scholar
• Nielsen K, van Tilborg A, Meijerink MR, et al. Incidence and treatment of local site recurrences following RFA of colorectal liver metastases. World J Surg. 2013;37:1340–1347.
   PubMed Web of Science ®Google Scholar
• Solbiati L, Ahmed M, Cova L, et al. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology. 2012;265:958–968.
   PubMed Web of Science ®Google Scholar
• Veltri A, Sacchetto P, Tosetti I, et al. Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol. 2008;31:948–956.
   PubMed Web of Science ®Google Scholar
• Hamada A, Yamakado K, Nakatsuka A, et al. Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates. Jpn J Radiol. 2012;30:567–574.
   PubMed Web of Science ®Google Scholar
• Abdalla EK, Vauthey J-N, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818–825. Discussion 825–827
   PubMed Web of Science ®Google Scholar
• de Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol. 2000;175:1619–1625.
   PubMed Web of Science ®Google Scholar
• Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36:166–175.
   PubMed Web of Science ®Google Scholar